Publication|Videos|February 13, 2025
Implementing Diversity, Equity, and Inclusion in Drug Development
Jennifer Kim, PhD, assistant research professor, Tufts School of Medicine, Tufts Center for the Study of Drug Development, discusses barriers to participation for underrepresented populations in clinical trials and how Tufts is conducting research to better understand their nature.
Advertisement
Episodes in this series
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Nature Medicine Retracts Viral Lung Cancer Timing Study After Four-Month Investigation
2
ACT Brief: Bridging Site-Sponsor Data Gaps, Major Study Retraction, and TNBC First-Line Approval
3
Real-Time Clinical Trial Oversight and the Infrastructure Gap: Q&A with Raj Indupuri, eClinical Solutions
4
ACT Brief: DIA Leadership Amid Uncertainty, Reimagining CRO Contracts, and Eli Lilly Expansion
5